MedPath

Identification of the mechanisms of 5-fluorouracil (5-FU)-induced Gastrointestinal (GI) toxicity in human colo

Conditions
EN: Gastrointestinal, 5-fluorouracil, Adverse effects, ToxicityNL: Gastrointestínaal, 5-fluorouracil, Schadelijke bijwerkingen, Toxiciteit
Registration Number
NL-OMON26903
Lead Sponsor
Maastricht University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Metastatic breast cancer patients receiving capecitabine monotherapy as their regular treatment;

- Age above 18 years old;

Exclusion Criteria

- Alcohol abuse up to 6 months before participation in this research, i.e. more than 4 drinks on any single day and more than 14 drinks per week for men and more than 3 drinks on any single day and more than 7 drinks per week for women

- Current presence of any diseases related to the gastrointestinal tract

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference in the whole genome transcriptomic response after exposure to 5-FU in colon epithelium.
Secondary Outcome Measures
NameTimeMethod
Molecular markers associated to 5-FU induced toxicity in the colon such as citrulline and calprotectin.
© Copyright 2025. All Rights Reserved by MedPath